Spotlight
Topic
News
Opinion
Brand Insights
Subscribe
Advertise
- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
FDA Designates NyokAssist As A Breakthrough Device
The device, developed by magAssist, is an interventional ventricular assistance device.
The FDA designated magAssist’s NyokAssist as a breakthrough device.
In a press release from magAssist, the company announced the decision. The designation identifies the NyokAssist as a novel device that has the potential to save lives and treat debilitating diseases.
The NyokAssist is a ventricular assistance device that features a foldable catheter pump. It has been designed to be quickly and easily inserted or removed from the human body. It also includes an external motor which reduces the risk of overheating and ensure sufficient blood flow.
Related Content
